🇺🇸 FDA
Patent

US 11053280

Anti-VEGF protein compositions and methods for producing the same

granted A61KA61K38/179A61K38/1866

Quick answer

US patent 11053280 (Anti-VEGF protein compositions and methods for producing the same) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/179, A61K38/1866, A61P, A61P17/06